TRICLEANSE Trademark

Trademark Overview

On Tuesday, February 4, 2020, a trademark application was filed for TRICLEANSE with the United States Patent and Trademark Office. The USPTO has given the TRICLEANSE trademark a serial number of 88783893. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Wednesday, August 25, 2021. This trademark is owned by Triad Life Sciences, Inc.. The TRICLEANSE trademark is filed in the Treatment & Processing of Materials Services category with the following description:

Processing of grafts, namely, processing biological tissue grafts made primarily of porcine extracellular matrix for wound treatment
tricleanse

General Information

Serial Number88783893
Word MarkTRICLEANSE
Filing DateTuesday, February 4, 2020
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateWednesday, August 25, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 9, 2020

Trademark Statements

Goods and ServicesProcessing of grafts, namely, processing biological tissue grafts made primarily of porcine extracellular matrix for wound treatment
Pseudo MarkTRI CLEANSE

Classification Information

International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateFriday, February 7, 2020
Primary Code040
First Use Anywhere DateMonday, November 30, 2020
First Use In Commerce DateMonday, November 30, 2020

Trademark Owner History

Party NameTriad Life Sciences, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMemphis, TN 38117
Party NameTriad Life Sciences, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMemphis, TN 38117

Trademark Events

Event DateEvent Description
Wednesday, August 25, 2021ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Wednesday, August 25, 2021ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Wednesday, August 25, 2021PREVIOUS ALLOWANCE COUNT WITHDRAWN
Wednesday, August 25, 2021WITHDRAWN FROM ISSUE - SENIOR ATTORNEY REQUEST
Wednesday, August 25, 2021ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, February 11, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, February 11, 2021NON-FINAL ACTION E-MAILED
Thursday, February 11, 2021SU - NON-FINAL ACTION - WRITTEN
Wednesday, February 10, 2021STATEMENT OF USE PROCESSING COMPLETE
Friday, January 22, 2021USE AMENDMENT FILED
Wednesday, February 10, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, January 22, 2021TEAS STATEMENT OF USE RECEIVED
Tuesday, August 4, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 9, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 9, 2020PUBLISHED FOR OPPOSITION
Wednesday, May 20, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, May 1, 2020ASSIGNED TO LIE
Thursday, April 23, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, April 23, 2020EXAMINER'S AMENDMENT ENTERED
Thursday, April 23, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, April 23, 2020EXAMINERS AMENDMENT E-MAILED
Thursday, April 23, 2020EXAMINERS AMENDMENT -WRITTEN
Thursday, April 23, 2020ASSIGNED TO EXAMINER
Friday, February 7, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, February 7, 2020NEW APPLICATION ENTERED IN TRAM

Related Keywords

tricleanse processing grafts matrix extracellular wound treatment porcine made namely biological